Home  /  Resource Library  /  Liposomal doxorubicin supercharge containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study

Liposomal doxorubicin supercharge containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study

Results of a study investigating liposomal doxorubicin as part of first line treatment of DLBCL or Hodgkin lymphoma.